Mymee is a pioneer in the use of self-evidence to support autoimmune disease and long COVID patients who continue to struggle with symptoms that are not resolved by their prescription drug regimen. Our clinically validated personalized trial and care platform was built to guide symptom improvements based on patients' unique triggers, needs and preferences.
Mymee provides statistically significant improvement across ten HRQoL domains as measured by PROMIS, including fatigue, pain, cognitive function, and ability to manage symptoms.*
See our latest research findings and learn more about becoming part of Mymee’s referral network to support your patients with persistent and uncontrolled symptoms.
Submit this form to receive our fact sheet and stay in touch for more information.
Learn more about how we support patients through self-evidence.
Read on for additional articles and insights related to Mymee’s program, research and use of self-evidence to guide significant improvements in quality of life.